Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Apr 27;59(18):7069-7075.
doi: 10.1002/anie.201916400. Epub 2020 Mar 11.

A Multi-action and Multi-target RuII -PtIV Conjugate Combining Cancer-Activated Chemotherapy and Photodynamic Therapy to Overcome Drug Resistant Cancers

Affiliations

A Multi-action and Multi-target RuII -PtIV Conjugate Combining Cancer-Activated Chemotherapy and Photodynamic Therapy to Overcome Drug Resistant Cancers

Johannes Karges et al. Angew Chem Int Ed Engl. .

Abstract

PtII complexes are commonly used to treat cancer. To reduce their side effects and improve their pharmacological properties, PtIV complexes are being developed as prodrug candidates that are activated by reduction in cancer cells. Concomitantly, RuII polypyridine complexes have gained much attention as photosensitizers for use in photodynamic therapy due to their attractive characteristics. In this article, a novel PtIV -RuII conjugate, which combines cancer activated chemotherapy with PDT, is presented. Upon entering the cancer cell, the PtIV centre is reduced to PtII and the axial ligands including the RuII complex and phenylbutyrate are released. As each component has its individual targets, the conjugate exerts a multi-target and multi-action effect with (photo-)cytotoxicity values upon irradiation up to 595 nm in the low nanomolar range in various (drug resistant) 2D monolayer cancer cells and 3D multicellular tumour spheroids.

Keywords: bioinorganic chemistry; metals in medicine; photodynamic therapy; platinum prodrugs.

PubMed Disclaimer

Similar articles

Cited by

References

    1. None
    1. A.-M. Florea, D. Büsselberg, Cancers 2011, 3, 1351-1371;
    1. C. Cullinane, G. B. Deacon, P. R. Drago, A. P. Erven, P. C. Junk, J. Luu, G. Meyer, S. Schmitz, I. Ott, J. Schur, L. K. Webster, A. Klein, Dalton Trans. 2018, 47, 1918-1932;
    1. Z. Wang, Z. Deng, G. Zhu, Dalton Trans. 2019, 48, 2536-2544;
    1. M. Hanif, C. G. Hartinger, Future Med. Chem. 2018, 10, 615-617;

Publication types

MeSH terms

LinkOut - more resources